Takakita To Go Ex-Dividend On March 28th, 2025 With 5 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Takakita(6325.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 5 JPY dividend per share. The ex-dividend
Takakita Co., Ltd. Reports Decline in Sales but Maintains Profitability
Takakita Co 9-Mos Parent Net Y538.00M Vs Net Y515.00M
Takakita: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Seiwa Construction, Kansai Electric Power Company, ZOZO, Shionogi, Daiichi Sankyo (31st)
※The above Calendar is just a plan and may be subject to change due to the company's circumstances.--------------------------------------- January 31 (Friday) <1803> Shimizu Construction <1878> Daito Construction <1884> Nihon Doro <1939> Shikoku Electric Engineering <1941> Chudenko <1942> Kansai Electric Engineering <1944> Kindan <1948> Koden Sha <1949> Sumitomo Electric.
Volume change rate ranking (9 o'clock) - Takase, Koyo Corporation, etc. ranked in.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the distribution day, one can understand the trends of selection and the interests of market participants. ■ Top volume change rates [As of December 4, 9:32] (Comparison of the average volume over the last five days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <9087> Takase 200142.92 400% 0% <7946> Koyo Co. 210084.98 357.11%
December 4th [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 JCR Pharma <4552> 727 yen (12/3) Human growth hormone preparation is the main product. The company announced that the first dose was administered to the first subject in the phase 1/2 clinical trial targeting mucopolysaccharidosis type 3B (MPS3B) in Japan for the blood-brain barrier penetrating α-N-acetylglucosaminidase preparation (JR-446) it developed. MPS3B is being co-developed and marketed with Medipal Holdings <7459>.
Focus on JCR Pharma and ABC Mart, while Uchida Yoko and Tsukishima HD are sluggish.
In the US stock market on the 3rd of yesterday, the dow jones industrial average closed down by $76.47 at 44,705.53, the nasdaq composite index rose by 76.96 points to 19,480.91, and the Chicago nikkei 225 futures were up by 90 yen compared to the Osaka daytime, at 39,240 yen. The exchange rate was 1 dollar = 149.50-150.00 yen. In today's Tokyo market, ABC Mart <2670> reported an increase in same-store sales of 14.7% in November, up from an increase of 6.3% in October, while another company also reported an increase in same-store sales of 8.9% in November and 6.3% in October.
Japan Machinery Orders Decline 2.9% in September
Takakita: Semi-Annual Report - Term 81 (2024/04/01 - 2025/03/31)
Takakita: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Daiichi Sankyo, Fujitsu, JR East Japan, ANA (31st)
※The above calendar is subject to change depending on the company's schedule.---------------------------------------October 31st (Thursday) <1777>Kawasaki Facilities <1798>Morita Shokai <1911>Sumitomo-Rin <1934>Yuatec <1939>Yondenko <1941>Chudenko <1942>Kandenko <1944>Kinden <194
Takakita: Notice regarding revisions to earnings forecasts
Takakita To Go Ex-Dividend On September 27th, 2024 With 5 JPY Dividend Per Share
September 26th (Japan Standard Time) - $Takakita(6325.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 5 JPY dividend per share. The ex-
Takakita Co., Ltd. Faces Sharp Quarterly Decline
Takakita: First quarter financial results for the March 2025 period (Japanese standard) (non-consolidated).
Takakita Co 1Q Parent Net Y44.00M Vs Net Y146.00M
Takakita: Extraordinary Report
Takakita: Confirmation letter
Takakita: Financial Report - Term 80 (2023/04/01 - 2024/03/31)